Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain

This publication has 45 references indexed in Scilit:

• Striatal Cannabinoid CB1 Receptor mRNA Expression Is Decreased in the Reserpine-Treated Rat Model of Parkinson's Disease
  Experimental Neurology, 2001
• Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
  The FASEB Journal, 2000
• D₂ dopamine receptors enable Δ⁹‐tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration
  British Journal of Pharmacology, 2000
• Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
  Published by Elsevier ,2000
• Anandamide, an Endogenous Cannabinoid Receptor Ligand, Also Interacts with 5-Hydroxytryptamine (5-HT) Receptor.
  Biological & Pharmaceutical Bulletin, 1998
• Pharmacology of cannabinoid CB1 and CB2 receptors
  Pharmacology & Therapeutics, 1997
• GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test
  Pharmacology Biochemistry and Behavior, 1996
• Pharmacology of Cannabinoid Receptors
  Annual Review of Pharmacology and Toxicology, 1995
• Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
  Science, 1992
• Neurotransmitters and neuromodulators in the basal ganglia
  Trends in Neurosciences, 1990